ABOS earnings date and last-quarter result: last quarter beat, P/E -1.18. Updated 2026-07-23.
Acumen Pharmaceuticals (ABOS) Research Hub
Acumen Pharmaceuticals (ABOS) trades on NASDAQ, US in the Healthcare (Biotechnology) sector. As of 2026-10-26, shares last closed at 2.27 USD (+14.65%), in a range — insufficient history for 200-DMA. Valuation: trailing P/E -1.18, market cap 0.13B. This hub links to the full technical, earnings and options research available for ABOS.
Last updated 2026-10-26 · Source: end-of-day prices (adjusted); indicators computed by SniperIQ
| Sector | Healthcare (Biotechnology) |
|---|---|
| Exchange | NASDAQ, US |
| Last close | 2.27 USD (+14.65%) |
| 52-week range | 1.62 USD – 3.34 USD |
| Trend regime | Range |
| 14-day RSI | 59 (Bullish) |
| Trailing P/E | -1.18 |
| Market cap | 0.13B |
| Dividend yield | 0.00% |
Available research for ABOS
Covered Call on ABOS: how it works, illustrative setup around the real 2.27 USD price, max profit/loss, breakeven and when to use it. Educational.
Iron Condor on ABOS: how it works, illustrative setup around the real 2.27 USD price, max profit/loss, breakeven and when to use it. Educational.
Protective Put on ABOS: how it works, illustrative setup around the real 2.27 USD price, max profit/loss, breakeven and when to use it. Educational.
ABOS technical analysis: range, last 2.27 USD, RSI 59, 52w range 1.62 USD–3.34 USD, real support/resistance. Updated 2026-10-26.
More on SniperIQ
Frequently asked questions
What sector is ABOS in?
Acumen Pharmaceuticals (ABOS) is classified under Healthcare (Biotechnology), listed on NASDAQ, US.
Is ABOS in an uptrend or downtrend?
As of 2026-10-26, ABOS is in a range — insufficient history for 200-DMA. See the full technical research page for support and resistance levels.
What is ABOS's trailing P/E ratio?
ABOS's trailing P/E is -1.18, with a market cap of 0.13B. See the earnings research page for full valuation detail.